| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/10/2001 | CA2388822A1 27 human secreted proteins |
| 05/10/2001 | CA2388511A1 Tissue specific genes of diagnostic import |
| 05/10/2001 | CA2388308A1 Gpcr-kd5 polypeptides and dna sequences thereof |
| 05/10/2001 | CA2387808A1 Human chemokine beta-13 |
| 05/10/2001 | CA2387801A1 Uteroglobin-like polynucleotides, polypeptides, and antibodies |
| 05/10/2001 | CA2387799A1 19 human secreted proteins |
| 05/10/2001 | CA2387754A1 10 human secreted proteins |
| 05/10/2001 | CA2387261A1 25 human secreted proteins |
| 05/10/2001 | CA2387136A1 26 human secreted proteins |
| 05/10/2001 | CA2386641A1 32 human secreted proteins |
| 05/10/2001 | CA2385665A1 Modulation of enos activity and therapeutic uses thereof |
| 05/10/2001 | CA2382455A1 Nucleic acids and proteins from group b streptococcus |
| 05/09/2001 | EP1097999A2 Abscisic acid responsive element-binding transcription factors |
| 05/09/2001 | EP1097995A1 Process for purification of human alpha interferon produced in yeast cells |
| 05/09/2001 | EP1097994A2 Human bad polypeptides, encoding nucleic acids and methods of use |
| 05/09/2001 | EP1097992A2 Modified bioluminescent proteins and their use |
| 05/09/2001 | EP1097945A2 Monoclonal and chimeric antibody specific for human tumor necrosis factor |
| 05/09/2001 | EP1097943A1 Process for the preparation of hyperpolymers of haemoglobin with uniform molecular weight |
| 05/09/2001 | EP1097942A2 Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of T-lymphocytes |
| 05/09/2001 | EP1097941A1 Substance capable of controlling the inclusion of exon 10 of the tau gene, and its therapeutic use against tauopathies |
| 05/09/2001 | EP1097940A1 Tumor antigen peptide originating in sart-1 |
| 05/09/2001 | EP1097719A1 NEP inhibitors for the treatment of female sexual dysfunction |
| 05/09/2001 | EP1097718A1 NPY antagonists for the treatment of female sexual dysfunction |
| 05/09/2001 | EP1097707A1 Treatment of female sexual dysfunction |
| 05/09/2001 | EP1097706A1 Phosphodiesterase inhibitors for the treatment of female sexual dysfunction |
| 05/09/2001 | EP1097239A2 Constitutive disease resistance gene (cdr1), and methods of use thereof |
| 05/09/2001 | EP1097235A2 Method for optimizing the production of adenovirus vectors |
| 05/09/2001 | EP1097234A1 Method for improving the gene transfer of genetic material in mammalian cells through the use of p21 (waf-1) |
| 05/09/2001 | EP1097233A2 Growth differentiation factor promoter and uses therefor |
| 05/09/2001 | EP1097231A1 Recombination repair gene, mim, from arabidopsis thaliana |
| 05/09/2001 | EP1097230A1 Chromatin associated proteins |
| 05/09/2001 | EP1097229A1 Process to collect metabolites from modified nectar by insects |
| 05/09/2001 | EP1097228A1 Method of making proteins in transformed yeast cells |
| 05/09/2001 | EP1097227A1 Cleavage of caulobacter produced recombinant fusion proteins |
| 05/09/2001 | EP1097226A1 Usurpin, a mammalian ded-caspase homologue that precludes caspase-8 recruitment and activation by the cd-95 (fas, apo-1) receptor complex |
| 05/09/2001 | EP1097225A1 Genes encoding sulfate assimilation proteins |
| 05/09/2001 | EP1097224A2 Genes encoding sulfate assimilation proteins |
| 05/09/2001 | EP1097221A2 Genes encoding sulfate assimilation proteins |
| 05/09/2001 | EP1097220A1 Genes encoding sulfate assimilation proteins |
| 05/09/2001 | EP1097215A1 Conditional mutants of influenza virus m2 protein |
| 05/09/2001 | EP1097214A2 Genes for the biosynthesis of anticapsin and bacilysine, their isolation and their use |
| 05/09/2001 | EP1097213A2 Vaccine against staphylococcus intoxication |
| 05/09/2001 | EP1097212A2 Anthrax vaccine |
| 05/09/2001 | EP1097211A2 Expression of eukaryotic peptides in plant plastids |
| 05/09/2001 | EP1097208A2 Compositions and methods for therapy and diagnosis of prostate cancer |
| 05/09/2001 | EP1097207A2 Multiple splice variants of the mu-opioid receptor gene |
| 05/09/2001 | EP1097206A1 Human calcium regulatory proteins |
| 05/09/2001 | EP1097204A2 Identification and characterization of splice variants of kappa3-related opioid receptor (kor3) gene |
| 05/09/2001 | EP1097203A1 Human presenilin-associated protein |
| 05/09/2001 | EP1097202A2 Human transport protein homologs |
| 05/09/2001 | EP1097201A1 Snurpotine i human m 3?g-cap specific nucleus import receptor protein with new domain structure, the production and use thereof |
| 05/09/2001 | EP1097199A1 71 human secreted proteins |
| 05/09/2001 | EP1097198A2 Soluble derivatives of anti-angiogenic peptides |
| 05/09/2001 | EP1097195A2 Screening of neisserial vaccine candidates and vaccines against pathogenic neisseria |
| 05/09/2001 | EP1097173A1 Peptides of il-2 and derivatives thereof and their use as therapeutic agents |
| 05/09/2001 | EP1097172A1 Anti hepatitis c virus antibody and uses thereof |
| 05/09/2001 | EP1097171A1 Method for purifying hemoglobin |
| 05/09/2001 | EP1097170A1 Growth hormone secretagogue related receptors and nucleic acids |
| 05/09/2001 | EP1097169A1 Mouse growth hormone secretagogue receptor |
| 05/09/2001 | EP1097168A2 Compounds and methods for modulating cadherin-mediated functions |
| 05/09/2001 | EP1097167A2 Neurotrophic growth factor |
| 05/09/2001 | EP1097166A2 Potassium channel polypeptide and polynucleotide compositions |
| 05/09/2001 | EP1097165A1 Novel inhibitors of angiogenesis and tumor growth |
| 05/09/2001 | EP1096953A1 Use of inactivated immunosuppressive and/or angiogenic immunogenic proteins, preparation method and pharmaceutical or vaccine uses |
| 05/09/2001 | EP1096946A2 Delta cleavage products and methods based thereon |
| 05/09/2001 | EP1096945A1 Lysine binding fragments of angiostatin |
| 05/09/2001 | EP0514411B1 Polypeptides and dna encoding same, associated with human malaria parasites |
| 05/09/2001 | CN1294632A Compsns. derived from i(mycobacterium vaccae) and methods for their use |
| 05/09/2001 | CN1294628A Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgroup B |
| 05/09/2001 | CN1294598A Epitopes in viral envelope proteins and specific antibodies directed against these eptitopes: use for detection of HCV viral antigen in host tissue |
| 05/09/2001 | CN1294597A Methods for treatment of diabetes using peptide analogues of insulin |
| 05/09/2001 | CN1294596A Method for reducing immunogenicity of proteins |
| 05/09/2001 | CN1294595A Hydrophobically-modified protein compsns, and methods |
| 05/09/2001 | CN1294194A Actin-binding protein and polynucleotide sequence for coding it |
| 05/09/2001 | CN1294193A Human Fb65L2-2 protein and polynucleotide sequence to code it |
| 05/09/2001 | CN1294016A Injection for giving up addiction |
| 05/09/2001 | CN1065568C Bacteriocins from streptococcus thermophilus |
| 05/09/2001 | CN1065538C Antibiotic stalobacins |
| 05/09/2001 | CN1065438C Cyclic adhesion inhibitors |
| 05/08/2001 | US6229072 Cytoplasmic male sterility system production canola hybrids |
| 05/08/2001 | US6229069 Method for controlling water content of plant |
| 05/08/2001 | US6229068 Method of increasing fruit size in a plant |
| 05/08/2001 | US6229064 Nucleotide sequence for development in absense of fertilization; transgenic plants |
| 05/08/2001 | US6229005 DNA sequences of enterically transmitted non-A/non-B hepatitis viral agent |
| 05/08/2001 | US6229004 Insecticidal protein fragments |
| 05/08/2001 | US6229003 Production of bovine growth hormone by microorganisms |
| 05/08/2001 | US6229002 Complex of nucleic acid which binds to platelet derived growth factor and nonimmunogenic, high molecular weight compound; for targeted diagnostic and therapy; anticarcinogenic agents; cardiovascular disorders; kidney disease |
| 05/08/2001 | US6229001 Mycobacterium fol a gene that encodes for the enzyme dihydrofolate reductase |
| 05/08/2001 | US6229000 Tissue-specific human neuronal calcium channel subtypes and their use |
| 05/08/2001 | US6228994 Labeled protein and its producing method, labeling compound to be used in the method, and method for analyzing function of genes |
| 05/08/2001 | US6228992 Proteins for control of nematodes in plants |
| 05/08/2001 | US6228991 Amino acid sequence; diagnosis, treatment or prevention of reproductive, developmental, neoplastic, and immunological/ autoimmune disorders; anticarcinogenic agents; antitumor/antiarthrtic/antidiabetic agents; endometriosis |
| 05/08/2001 | US6228990 Crystal of ligand binding domain complexed with raloxifine |
| 05/08/2001 | US6228987 Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic LHRH peptides |
| 05/08/2001 | US6228984 Polypeptides their production and use |
| 05/08/2001 | US6228983 Peptides from transmembrane protein, gp41, from human immunodeficiency virus; viricides; drug screening; intracellular modulators of coiled-coil peptide structures |
| 05/08/2001 | US6228982 Stable compounds that form double-stranded, helical structures mimicking double-stranded dna; diagnosis; prophylaxis; therapy; antisense agents |
| 05/08/2001 | US6228846 Polynucleotide vaccine formula against canine pathologies |
| 05/08/2001 | US6228840 Administering n-anisoylated heptapeptide to inhibit melanocyte stimulating hormone; treating melanomas |
| 05/08/2001 | US6228838 Bactericide or antibiotic screening; genetic engineering |